BACKGROUND: Before April 2003, all male detainees were offered chlamydia (CT) and gonorrhea (GC) screening tests, after which services were limited to symptom-based testing. In 2003, male screening was discontinued at a large urban county jail. OBJECTIVE: To evaluate the impact of discontinuing universal male sexually transmitted disease screening in a large county jail. METHODS: We compared the number of male CT/GC cases during the periods of universal screening (April 2002 to March 2003) with symptom-based testing (April 2003 to March 2004). RESULTS: The number of reported CT/GC cases among male detainees declined by -91.7% (3329-277) and -90.5% (1133-108), respectively after universal screening was discontinued. Citywide, CT/GC cases among males and females declined by -9.3% (24,885-22,563) and -12.9% (13,249-11,541), respectively. CONCLUSIONS: Discontinuation of universal male CT/GC screening services at a large county jail represents a missed opportunity to screen a high-risk population and was associated with substantial declines in reported morbidity.
BACKGROUND: Before April 2003, all male detainees were offered chlamydia (CT) and gonorrhea (GC) screening tests, after which services were limited to symptom-based testing. In 2003, male screening was discontinued at a large urban county jail. OBJECTIVE: To evaluate the impact of discontinuing universal male sexually transmitted disease screening in a large county jail. METHODS: We compared the number of male CT/GC cases during the periods of universal screening (April 2002 to March 2003) with symptom-based testing (April 2003 to March 2004). RESULTS: The number of reported CT/GC cases among male detainees declined by -91.7% (3329-277) and -90.5% (1133-108), respectively after universal screening was discontinued. Citywide, CT/GC cases among males and females declined by -9.3% (24,885-22,563) and -12.9% (13,249-11,541), respectively. CONCLUSIONS: Discontinuation of universal male CT/GC screening services at a large county jail represents a missed opportunity to screen a high-risk population and was associated with substantial declines in reported morbidity.
Authors: Mark Malek; Alexander R Bazazi; Garrett Cox; Germaine Rival; Jacques Baillargeon; Armidia Miranda; Josiah D Rich Journal: J Correct Health Care Date: 2011-01
Authors: Marjan Javanbakht; Melina Boudov; Laura J Anderson; Mark Malek; Lisa V Smith; Michael Chien; Sarah Guerry Journal: Am J Public Health Date: 2014-09-11 Impact factor: 9.308
Authors: Chaitra Gopalappa; Ya-Lin A Huang; Thomas L Gift; Kwame Owusu-Edusei; Melanie Taylor; Vincent Gales Journal: Sex Transm Dis Date: 2013-10 Impact factor: 2.830
Authors: Kyle J Popovich; Stephanie N Thiede; Chad Zawitz; Alla Aroutcheva; Darjai Payne; William Janda; Michael Schoeny; Stefan J Green; Evan S Snitkin; Robert A Weinstein Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079